Avalo Therapeutics, Inc.
AVTX
$18.21
-$1.50-7.61%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/9/2026
-
MarketBeat
9/9/2026
-
Tickeron - Stocks
9/5/2026
-
Tickeron - Stocks
9/5/2026
-
MarketBeat
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
9/4/2026
-
Globe Newswire
9/4/2026
-
SeekingAlpha
9/4/2026
-
Seeking Alpha - Long Ideas
9/4/2026
-
Tickeron - Stocks
9/3/2026
-
Globe Newswire
9/3/2026
-
Tickeron - Stocks
9/3/2026
-
MarketBeat
9/2/2026
-
Tickeron - Stocks
Avalo Therapeutics (AVTX, $18.95) Stochastic Oscillator left the oversold zone on September 01, 2026
9/2/2026
-
Tickeron - Stocks
9/1/2026
-
MarketBeat
9/1/2026
-
MarketBeat
8/27/2026
-
Tickeron - Stocks
8/26/2026
-
MarketBeat
8/25/2026
-
Tickeron - Stocks
8/25/2026
-
Tickeron - Stocks
8/18/2026
-
Simply Wall St
8/18/2026
-
The Cerbat Gem
8/16/2026
-
MarketBeat
8/13/2026
-
Tickeron - Stocks
8/13/2026
-
Tickeron - Stocks
8/12/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
410 522 8707
Address
1500 Liberty Ridge Drive
Suite 321
Wayne, PA 19087
Suite 321
Wayne, PA 19087
Country
Year Founded
Business Description
Sector
Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes...
more